Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-05-03 @ 9:44 PM
Study NCT ID:
NCT07329868
Status:
COMPLETED
Last Update Posted:
2026-01-09
First Post:
2025-12-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of ACT and CBSM for Caregivers in Cancer
Sponsor:
Ardakan University
Organization:
Study Overview
Official Title:
Comparing the Effectiveness of Acceptance and Commitment Therapy and Cognitive Behavioral Stress Management on Fear of Recurrence, Quality of Life, Psychological Distress, and Fatigue of Caregivers of Cancer Patients
Status:
COMPLETED
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the effectiveness of cognitive-behavioral stress management (CBSM) and acceptance and commitment therapy (ACT) on the fear of recurrence, quality of life, psychological distress, and fatigue of caregivers of cancer patients.
Researchers compare the effectiveness of CBSM and ACT to a Control(without receiving intervention) to see if treatment works to improve the health of caregivers of cancer patients. A comparison between the two treatments was also conducted to determine if there was a difference in their effectiveness.
Participants:
In this study, 66 participants were randomly assigned to one of three groups: the CBSM group, the ACT group, or the control group.
The CBSM and ACT groups each attended eight 90-minute, in-person sessions twice a week.
Researchers compare the effectiveness of CBSM and ACT to a Control(without receiving intervention) to see if treatment works to improve the health of caregivers of cancer patients. A comparison between the two treatments was also conducted to determine if there was a difference in their effectiveness.
Participants:
In this study, 66 participants were randomly assigned to one of three groups: the CBSM group, the ACT group, or the control group.
The CBSM and ACT groups each attended eight 90-minute, in-person sessions twice a week.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: